Ultrasonographic examination of rheumatoid arthritis patients who are free of physical synovitis: Power Doppler subclinical synovitis is associated with bone erosion

Article (PDF Available)inRheumatology (Oxford, England) 53(3) · December 2013with32 Reads
DOI: 10.1093/rheumatology/ket405 · Source: PubMed
Objective: The aim of this study was to investigate the characteristics of power Doppler (PD) subclinical synovitis in patients with RA who achieve clinical remission free from physical synovitis. Methods: Twenty-nine RA patients were consecutively enrolled. All of the patients had achieved clinical remission [simplified disease activity index (SDAI) 3.3] for at least 6 months at the musculoskeletal ultrasound (MSKUS) examination. Additionally, none of the patients exhibited tender joints at 68 sites or swollen joints at 66 sites. MSKUS of bilateral wrist and finger joints, including the first to fifth MCP joints, the first IP joint and the second to fifth PIP joints, was performed and the findings obtained by grey scale (GS) and PD were graded on a semi-quantitative scale from 0 to 3. Results: The median disease duration upon the introduction of DMARDs was 3 months and that at MSKUS examination was 21 months. The percentages of patients with PD synovitis in at least one joint were PD grade 1, 58.6%; PD grade 2, 31.0% and PD grade 3, 6.9%. The use of biological agents was low in patients with PD synovitis grade 2 (P < 0.05). The presence of US bone erosion was high by patient (P < 0.05) and by joint (P < 0.0001) with PD synovitis as compared with those without PD synovitis. However, no correlations were found between PD synovitis measures and serum biomarkers, including angiogenesis factors. Conclusion: PD subclinical synovitis correlates with several clinical characteristics, whereas conventional serum biomarkers are not useful for indicating the presence of subclinical PD synovitis.

Full-text (PDF)

Available from: Katsumi Eguchi, Feb 12, 2016
  • [Show abstract] [Hide abstract] ABSTRACT: There have been immense technical innovations and broadened clinical applications of ultrasound in the musculoskeletal system over the past 20 years. Specifically with regard to the hand and wrist, the advent of higher resolution transducers and postprocessing software applications have resulted in overall enhanced visualization of soft tissue structures (tendons/ligaments) as well as surface osseous lesions such as subclinical erosions in rheumatoid arthritis. Quantitative ultrasound, using either power Doppler or contrast-enhanced imaging, has become a central outcomes measure used to evaluate and document patient response to treatment in inflammatory arthropathies such as rheumatoid arthritis. This review will summarize the current state of clinical applications of ultrasound in the evaluation of the hand and wrist, with a summary of technical advances and specific applications in rheumatologic conditions.This review was exempt from institutional review board approval.
    Article · Sep 2014
  • [Show abstract] [Hide abstract] ABSTRACT: Rheumatoid arthritis (RA) is a chronic disease characterized mainly by joint inflammation that can lead to permanent structural damage. An accurate assessment of joint inflammation is of outmost importance for disease management. Over the past years, musculoskeletal ultrasound (MSUS) has proved to be a sensitive tool not only in detecting joint and periarticular inflammation, i.e., synovitis, tenosynovitis, and bursitis, but also in evaluating structural damages such as erosion and tendon damage. In addition to clinical and laboratory evaluation, MSUS has been successfully used to early diagnose RA. In RA patients, B-mode (BM) and Doppler techniques characterize better than clinical assessment joint inflammation (either synovial hypertrophy or effusion, either active or inactive synovitis) and reflect accurately disease inflammatory activity. Doppler-detected synovitis has been shown to be predictive for structural damage, even in patients in clinical remission. Furthermore, MSUS has proved successful in monitoring response to treatment and is also a valuable tool for guiding MSUS injections.
    Chapter · Jan 2015 · Disease markers
  • [Show abstract] [Hide abstract] ABSTRACT: Structural damage in rheumatoid arthritis (RA) occurs early if inflammation is not treated promptly. Treatment targeted to reduce inflammation, in particular, that of synovial inflammation in the joints (synovitis), has been recommended as standard treat-to-target recommendations by rheumatologists. The goal is to achieve disease remission (i.e., no disease activity). Several accepted remission criteria have not always equated to the complete absence of true inflammation. Over the last decade, musculoskeletal ultrasonography has been demonstrated to detect subclinical synovitis not appreciated by routine clinical or laboratory assessments, with the Power Doppler modality allowing clinicians to more readily appreciate true inflammation. Thus, targeting therapy to Power Doppler activity may provide superior outcomes compared with treating to clinical targets alone, making it an attractive marker of disease activity in RA. However, more validation on its true benefits such as its benefits to patients in regard to patient related outcomes and issues with standardized training in acquisition and interpretation of power Doppler findings are required.
    Full-text · Article · May 2015
Show more